SCHEMBL431429

SCHEMBL431429

CCCC(O)CC(O)CC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
TSHR P16473 4/20 0.35
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
STAT3 P40763 1/20 0.31
CYP3A4 P08684 1/20 0.31
NFKB1 P19838 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
FDPS P14324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14337559 1.00 LMNA (0.39) LMNATSHRCHRM1AKR1A1CHRM3
SCHEMBL3097246 1.00 LMNA (0.39) LMNATSHRCHRM1AKR1A1CHRM3
SCHEMBL14581986 0.97 LMNA (0.37) LMNATSHRCHRM1AKR1A1CHRM3
SCHEMBL15255500 0.95 LMNA (0.36) LMNATSHRFDPS
SCHEMBL18853831 0.92 LMNA (0.34) LMNATSHRCYP3A4NFKB1
SCHEMBL28576046 0.91 TSHR (0.38) LMNATSHRCHRM1AKR1A1CHRM3
SCHEMBL16153750 0.91 TSHR (0.38) LMNATSHRCHRM1AKR1A1CHRM3
SCHEMBL3096199 0.91 TSHR (0.38) LMNATSHRCHRM1AKR1A1CHRM3
SCHEMBL3096192 0.91 TSHR (0.38) LMNATSHRCHRM1AKR1A1CHRM3
SCHEMBL18719466 0.90 GPR84 (0.33) LMNACYP3A4NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2025-02-06 US claimed
EP-4451875-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2024-10-30 EP claimed
WO-2023122003-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2023-06-29 WO claimed
WO-2023111464-A1 POLYURETHANE-BASED COMPOSITION BOSTIK SA (FR) 2023-06-22 WO claimed
US-20230147032-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS HERAEUS EPURIO GMBH (DE) 2023-05-11 US claimed
WO-2021198214-A2 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co. KG (DE) 2021-10-07 WO claimed
EP-3889980-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co KG (DE) 2021-10-06 EP claimed
CN-107635649-B Combination of chemical additives for increasing water flux of membranes LG 纳米水公司 2020-12-15 CN claimed
CN-111001961-A Method for preparing micro solder balls for electronic packaging in batch based on ball forming paste printing technology and automatic device 北京工业大学 2020-04-14 CN claimed
CN-110407964-A Catalyst component for olefin and preparation method thereof CHINA PETROLEUM & CHEM CORP 2019-11-05 CN claimed
WO-1998011854-A1 HYDROPHILIC POLYETHER POLYURETHANES CONTAINING CARBOXYLIC ACID TYNDALE PLAINS-HUNTER, LTD. (US) 1998-03-26 WO claimed
EP-0802954-A1 METHOD OF PRINTING, PRINTING INK AND A METHOD OF MANUFACTURING THE SAME, AND THE USE THEREOF Druckfarbenfabrik Gebr. Schmidt GmbH (DE) 1997-10-29 EP claimed
WO-1997034972-A1 FABRIC SOFTENING COMPOUND/COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO claimed
WO-1997023540-A1 POLYMERIC FLUORESCENCE QUENCHING COMPOUNDS AND THEIR USE EASTMAN CHEMICAL COMPANY (US) 1997-07-03 WO claimed
WO-1997003170-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO claimed
WO-1997003169-A1 CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO claimed
WO-1996021702-A1 METHOD OF PRINTING, PRINTING INK AND A METHOD OF MANUFACTURING THE SAME, AND THE USE THEREOF DRUCKFARBENFABRIK GEBR. SCHMIDT GMBH (DE) 1996-07-18 WO claimed
EP-0363057-A2 Permanent wave solution REDKEN LABORATORIES INC. (US) 1990-04-11 EP claimed
EP-0066176-B1 FOUNTAIN SOLUTIONS SUITABLE FOR USE IN LITHOGRAPHIC OFFSET PRINTING UNION CARBIDE CORPORATION (US) 1985-01-09 EP claimed
US-4181638-A EXCESS HYSROXYL GROUPS WHITTAKER CORPORATION 1980-01-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF RASGRP3, RSU1, RPP30 LMNA 2815/4885TSHR 4641/4885CHRM1 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.